DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 3.97% to $5.80 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.64% to 16,831.48 and the Dow Jones Industrial Average rising 0.78% to 40,524.79.
The stock's fall snapped a six-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 90.63% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 5.57% to $4.36, Fortress Biotech Inc. (FBIO) rose 7.53% to $1.57, and Viking Therapeutics Inc. $(VKTX)$ rose 10.58% to $24.57.
Trading volume (122,369) remained 127,586 below its 50-day average volume of 249,955.
Data source: Dow Jones Market Data, FactSet. Data compiled April 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 14, 2025 17:24 ET (21:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.